Compass Pathways (CMPS) said Friday it has priced an underwritten offering of about 24 million American depositary shares and pre-funded warrants at $4.275 per ADS and accompanying ADS warrant, and about $4.265 per pre-funded warrant to buy up to about 11 million ADSs and accompanying ADS warrant.
Gross proceeds from the offering, expected to close around Monday, are expected to be roughly $150 million and up to about $353 million if the ADS warrants are fully exercised, the company said.
Compass said it plans to use the net proceeds and its existing cash and cash equivalents to finance ongoing phase 3 studies in treatment-resistant depression, advance its post-traumatic stress disorder program, and for general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.